changing from semaglutide to zepbound Switching Tirzepatide Switching Semaglutide to Tirzepatide: A

Retatrutide appears to: Target deep abdominal fat Reduce waist circumference more significantly Improve metabolic syndrome components Safety and Tolerability Side Effects: Similar to GLP-1 Agonists Nausea Vomiting Diarrhea or constipation Fatigue in early weeks Mitigation strategy: Start at low doses and titrate slowly Consider antiemetics in sensitive patients While retatrutides triple action raises theoretical concerns, early data show comparable tolerability to tirzepatide , with no increase in severe adverse events

The majority of patients taking semaglutide do not experience dermatological reactions

If you experience any side effects, including skin reactions, you can report them directly to the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)

Lewis, G

Yes but choose complex carbohydrates and watch portions